// App-Quantinova.ai

PB0929 : Comparison between full dose and reduced dose enoxaparin in the management of cancer-associated venous thromboembolism

Researchers

Presenter

  • J. Ong

Principal Investigators

  • E. Leitinger

  • S. Chunilal

Medical Centers

  • MonashHeart, Melbourne, Victoria, Australia

  • Monash Health, Clayton, Australia

  • Monash Health, Clayton, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved